Printer Friendly

ENDOTRONICS, INC. PURCHASES VERAX CORPORATION PRODUCT LINE

 MINNEAPOLIS, May 12 /PRNewswire/ -- Endotronics, Inc. (NASDAQ: ENDO) announced today that as of May 11, 1993, the agreement to purchase certain product line assets and technology from the New Hampshire-based Verax Corporation was finalized. In connection with such acquisition, the company acquired a series of cell culture products from Verax which utilize a fluidized bed bioreactor technology.
 In commenting on the agreement, Richard E. Sakowicz, president and chief operating officer of Endotronics, said, "With this addition to our product line, Endotronics can now provide its customers the most diversified set of large-volume automated, mammalian cell culture systems in the industry. The systems in each series accommodate the customers' requirements from process development to commercial scale production."
 Endotronics, Inc., headquartered in Minneapolis, is dedicated to providing cell processing products and services to meet the needs of human health care and biotechnology markets worldwide.
 -0- 5/12/93
 /COINTACT: Yvonne L. Marschner-Bova, director-Investor Relations, Endotronics, 313-871-7350/
 (ENDO)


CO: Endotronics, Inc.; Verax Corporation ST: Minnesota, New Hampshire IN: MTC SU: TNM

ML -- DE010 -- 7477 05/12/93 10:31 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 12, 1993
Words:177
Previous Article:ROCKY SHOES AND BOOTS, INC. ANNOUNCES THIRD QUARTER RESULTS
Next Article:MARION MERRELL DOW GETS GO-AHEAD TO LAUNCH PENTASA IN UNITED STATES FOR ULCERATIVE COLITIS
Topics:


Related Articles
ENDOTRONICS SIGNS PRODUCTION AND MARKETING AGREEMENT WITH HELIXYS
ENDOTRONICS RECEIVES JAPANESE PATENT ON CELL CULTURE TECHNOLOGY
ENDOTRONICS, INC. ANNOUNCES PURCHASE OF OPTICELL(TM) CELL CULTURE PRODUCT LINE FROM CHARLES RIVER LABORATORIES
ENDOTRONICS, INC. ANNOUNCES RESULTS FOR THE THIRD QUARTER AND NINE MONTHS ENDED JUNE 30, 1992
ENDOTRONICS REPORTS FOURTH-QUARTER AND FISCAL 1992 YEAR-END RESULTS
ENDOTRONICS, INC. UPGRADES PRODUCTION FACILITY AND SIGNS CYTOGEN CORPORATION CONTRACT
ENDOTRONICS REPORTS RESULTS FOR ITS FIRST QUARTER ENDED DEC. 31, 1992
ENDOTRONICS, INC. ANNOUNCES REALIGNMENT; HORWATH PROMOTED TO VICE PRESIDENT AND GENERAL MANAGER OF BIOPROCESSING BUSINESS UNIT
CELLEX BIOSCIENCES, INC. REPORTS THE COMPLETION OF SECONDARY OFFERING AND RESULTS OF ITS SECOND QUARTER AND SIX MONTHS ENDED MARCH 31, 1993
CELLEX BIOSCIENCES ENTERS INTO DISTRIBUTION AGREEMENT WITH RECEPTOR TECHNOLOGIES LIMITED OF ENGLAND

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters